Article,

The transfer and commercialization of university-developed medical imaging technology: opportunities and problems

, , , and .
IEEE Transactions on Engineering Management, 46 (3): 289--298 (1999)
DOI: 10.1109/17.775281

Abstract

Superconducting quantum interference devices (SQUID's) are sensitive devices designed to measure very weak magnetic fields, The noninvasive nature of these devices makes them ideal in clinical applications for the measurement of biomagnetic signals associated with the human body, such as the brain and the heart, Commercial acceptance of this technology, however, has been hindered by technical limitations and high operational costs. Moreover, the advanced medical instrument market is uncertain as a result of health care reform and the related pressures of cost containment. The aging U.S. population, however, will likely increase the demand for cardiovascular care and thereby present opportunities for SQUID medical instruments, This paper discusses a university-based attempt to transfer and commercialize technology that potentially could eliminate the technical limitations of SQUID devices and allow their use in typical clinical environments. At this point in the development process, this technology can be termed neither a success nor a failure. Based on the experiences thus far, however, certain lessons can be drawn for technology transfer of university-developed medical technologies. First, universities need to re-examine the issue of the incentives to publish versus the incentives to protect intellectual property. Failure to properly align these incentives is likely to weaken or eliminate the potential for a strong intellectual-property position. Second; although a number of technology-transfer strategies are potentially available to universities, three factors are critical in making this selection: 1) the strength of proprietary position; 2) the stage of development; and 3) the breadth of potential applications for the technology. Moreover, university technology-transfer offices need to take a businesslike approach in identifying appropriate technology-transfer strategies that match the technology, the marketplace, and commercialization potential. For universities seeking to commercialize medical technologies it is critical to expand collaborations with medical professionals to validate the clinical application of the technology. Finally, where possible, partnerships with medical device companies should be pursued to gain experience in product development.

Tags

Users

  • @kamil205

Comments and Reviews